Erbagil scientific publications
In the Scientific Evidence section, Erbagil shares the results and studies that represent the heart of its innovation. This space is dedicated to the publication of scientific texts , articles and research that attest to the effectiveness of our products and patented technologies, such as Ozoile® and other advanced solutions. Each document presented here testifies to our constant commitment to research and development of cutting-edge solutions, the result of collaborations with internationally renowned research institutes and scientists.
Erbagil has always believed in the importance of a solid scientific basis to support the efficacy and safety of its medical devices and cosmetics. The scientific evidence that you will find in this section is the result of rigorous and certified studies that demonstrate how our innovative patents improve the quality of life and well-being of people. Each publication represents a step forward in our path to excellence, making visible the link between science, innovation and health .
Updated ERBAGIL bibliography
Latest publications
Cassaro F.; Ieni A.; Currò M.; Pizzimenti C.; Irrera N.; Vaccaro F.; Maisano G.; D'Antoni S.;
Impellizzeri P.; Romeo C.; Arena S. Ozonides extravirgin olive oil as an
alternatives to steroids in controlling proliferative behavior in penile lichen
sclerosus: a comparative study in pediatric population. Pediatr Surg Int.
2025 May 20;41(1):140.
https://pubmed.ncbi.nlm.nih.gov/40392382/
Vella, S.; Della Greca, M.; Tuzi, A.; Cermola, F. Characterization of Pure Ozonides
from Ozonolysis of Oleic Acid Methyl Ester; Use of a Protocol for the Analysis
of the Corresponding Stable Ozonides from Triolein and Organic Extra Virgin
Olive Oil (+OIL®). Molecules 2025, 30, 507. https://doi.org/10.3390/molecules30030507
Saija, C.; Currò, M.; Arena, S.; Bertuccio, MP; Cassaro, F.; Montalto, A.S.; Colonna, M.R.; Caccamo, D.; Romeo, C.; Impellizzeri, P. Possible Role of NRF2 in Cell Response to OZOILE (Stable Ozonides) in Children Affected by Lichen Sclerosus of Foreskin . Curr. Issues Mol. Biol. 2024, 46, 9401–9414. https:// doi.org/10.3390/cimb46090557
CONFERENCES & WORKSHOPS
Crucianelli S., Ciprandi G., Grussu F., Spione F., Dicorato P., Pisani M. New Approach to pediatric burns: comparing stable ozonides and silver sulphadiazine. EPUAP 25-27 September 2024, Lausanne, Switzerland
De Angelis B. PhD MD, Di Segni C. PhD MD, Fernandes M. MD, Orlandi F.PhD MD, Prof. Cervelli V. , Management protocol of superinfected psoriasis with Ozoile®. XVII AIUC National Congress, 11-14 October 2023, Turin, Italy
De Angelis B. PhD MD, Di Segni C. PhD MD, Fernandes M. MD, Orlandi F.PhD MD, Prof. Cervelli V, Use of the non-rinse detergent based on Ozoile®, Lactic Acid and Decyl-Glucoside in the concept of Wound Hygiene. XVII AIUC National Congress, 11-14 October 2023, Turin, Italy
scientific evidence
Erbagil Obtains European Patent for Ozoile®️: A New Milestone in Scientific Innovation
We are proud to announce that the European Patent Office (EPO) has officially registered the European Patent for Ozoile®️ with unitary effect. This milestone marks a significant step for Erbagil and demonstrates the company's continued commitment to research and development of innovative solutions in the field of health and well-being. Ozoile®️: A Green Technology at the Service of Health Ozoile®️ is the result of a patented technology that combines the power of ozone with the fatty acids of organic extra virgin olive oil (+OIL). This innovative blend of stable ozonides acts as a modulator of cellular redox balances, stimulating the...
